title: O6-methylguanine-DNA methyltransferase in pretreatment tumour biopsies as a predictor of response to temozolomide in melanoma.
abstract: Resistance of tumour cells to methylating and monochloroethylating agents in vitro and in vivo has been linked to levels of the DNA repair protein O6-methylguanine-DNA methyltransferase (MGMT). In a clinical trial of temozolomide in advanced malignant melanoma, the relationship between pretreatment MGMT levels in biopsies of cutaneous tumours and involved lymph nodes and clinical response to the drug has been studied. Among 50 evaluable patients, there were three complete responses (CR), four partial responses (PR), six with stable disease (SD) and 37 with progressive disease (PD), with an overall response rate of 14%. In 33 patients in whom MGMT level and clinical response could be evaluated, the tumour MGMT levels (fmol mg(-1) protein) were: CR, 158 +/- 119; PR, 607 +/- 481; NC, 171 +/- 101; PD, 185 +/- 42.3. Thus, measurements of pretreatment levels of MGMT in melanoma did not predict for response to temozolomide.
authors.affiliation: Department of Medical Oncology, Christie Hospital NHS Trust, Manchester, UK.
authors.forename: M R
authors.initials: MR
authors.lastname: Middleton
authors.forename: J M
authors.initials: JM
authors.lastname: Lunn
authors.forename: C
authors.initials: C
authors.lastname: Morris
authors.forename: G
authors.initials: G
authors.lastname: Rustin
authors.forename: S R
authors.initials: SR
authors.lastname: Wedge
authors.forename: M H
authors.initials: MH
authors.lastname: Brampton
authors.forename: M J
authors.initials: MJ
authors.lastname: Lind
authors.forename: S M
authors.initials: SM
authors.lastname: Lee
authors.forename: D R
authors.initials: DR
authors.lastname: Newell
authors.forename: N M
authors.initials: NM
authors.lastname: Bleehen
authors.forename: E S
authors.initials: ES
authors.lastname: Newlands
authors.forename: A H
authors.initials: AH
authors.lastname: Calvert
authors.forename: G P
authors.initials: GP
authors.lastname: Margison
authors.forename: N
authors.initials: N
authors.lastname: Thatcher
mesh_terms: D000328:Adult; D018906:Antineoplastic Agents, Alkylating / Q000627:therapeutic use*; D001706:Biopsy; D003606:Dacarbazine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007963:Leukocytes, Mononuclear / Q000201:enzymology; D008207:Lymphatic Metastasis; D008297:Male; D008545:Melanoma / Q000188:drug therapy* / Q000201:enzymology* / Q000473:pathology; D008875:Middle Aged; D019853:O(6)-Methylguanine-DNA Methyltransferase / Q000097:blood / Q000378:metabolism*; D011237:Predictive Value of Tests; D011446:Prospective Studies; D000077204:Temozolomide
chemical_list: D018906:Antineoplastic Agents, Alkylating; D003606:Dacarbazine; D019853:O(6)-Methylguanine-DNA Methyltransferase; D000077204:Temozolomide